Google DeepMind, Google LLC’s artificial intelligence research unit, today detailed a new version of its AlphaFold neural network for biologists. One of the factors that influence the behavior of a ...

Google’s DeepMind AlphaFold team is taking the wraps off its latest model, the AlphaFold 3, a model that can be employed by researchers to develop new drugs, life science innovations. This new model ...

Google DeepMind has expanded its AlphaFold AI system to not only predict the structure of proteins, but also to model how proteins interact with other cell structures, including DNA, RNA, and small ...

Posts from this topic will be added to your daily email digest and your homepage feed. AlphaFold 3 uses the same method as AI image generators to predict how different molecules fit together.

Researchers at Google DeepMind have developed AlphaFold 3, an AI model that can predict the structure of and interactions between biological molecules including proteins, DNA and RNA, and small ...

Last month, Demis Hassabis and John Jumper of Google DeepMind were jointly awarded the 2024 Nobel Prize in Chemistry for their development of AlphaFold 3. This AI model can more accurately predict the ...

Google spent much of the past year hustling to build its Gemini chatbot to counter ChatGPT, pitching it as a multifunctional AI assistant that can help with work tasks or the digital chores of ...

Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more Google DeepMind and Isomorphic Labs today ...

Krystle Vermes is a Boston-based news reporter for Android Police. She is a graduate of the Suffolk University journalism program, and has more than a decade of experience as a writer and editor in ...

The artificial intelligence–based structure-prediction software AlphaFold, originally developed by Google DeepMind, has quickly become an important tool for drug discovery. Its original iteration ...

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...